News Room
News
BeyondDX selects the Ministry of SMEs and Startups Deep Tech-TIPS...Get up to 1.7 billion won in support such as R&D
2024-06-17 13:39:13
https://www.yakup.com/news/index.html?mode=view&cat=12&nid=295666
BeyondDX selects the Ministry of SMEs and Startups Deep Tech-TIPS...Get up to 1.7 billion won in support such as R&D
T-cell-based immune environment profiling platform 'iDX Gate IO' spurts commercialization
BeyondDx (CEO Jung Sojin), a multi-integrated analysis solution company, announced on the 17th that it has been selected as a private investment-led technology start-up support program "Deep-Tech TIPS" by the Ministry of SMEs and Startups.
Deep Tech Tips is part of the Super Gap Startup 1000+ Project announced by the Ministry of SMEs and Startups to select and foster promising startups in 10 new industries, and it is a project that provides up to 1.7 billion won in commercialization and overseas marketing funds, including 1.5 billion won in R&D expenses to selected companies.
Beyond DX is a liquid biopsy-based multi-integrated analysis solution development and diagnostic company that was founded in August 2023 and operates a unique pipeline and specialized technology for diseases with high socio-economic needs.
The difference between BeyondDx and existing liquid biopsy companies is that it uses blood as an analyte, but it combines biomarkers such as protein biomarkers, blood tumor cells, blood tumor DNA, and T cells in order to establish an optimal diagnostic system.
Among the diagnostic platforms it has, this Deep Tech tip targets iDX Gate IO (TCR profiling) solution based on T cells, and quickly profiles the characteristics of T cells (neo-antigen response TCR combination) that respond to cancer environments so that they can be applied to immune-based customized treatment.
The key technologies that make up iDXGate IO are the Any-Hold IO System, which captures T cells that directly react with tumor antigens, and the Immunity clustering of Lymphocyte units by TCR (iCLUST), a TCR (T-cell receptor) pattern algorithm that can determine the reactivity of T cells following treatment.
An official from BeyondDx said, "iDXGate IO core technology is designed to predict and monitor the reactivity and side effects of treatment in real time, so it will be a technology that can overcome the limitations of immune environment profiling techniques, including existing immune companion diagnostics."
Meanwhile, since November last year, BeyondDx has been conducting collaborative research using iDXGate IO with 'Senlang Bio', a Chinese-based cell therapy company. With the selection of Deep Tech Tips, BeyondDx plans to accelerate its global expansion.